SlideShare une entreprise Scribd logo
1  sur  28
HIV / AIDS
-Malini Sundar Rajan
7th
semester BE Biotechnology
PESIT
2
Endemic, Epidemic and Pandemic
– The Difference
 Endemic: a disease that exists permanently in a
particular region or population. Malaria is a
constant worry in parts of Africa.
 Epidemic: An outbreak of disease that attacks
many peoples at about the same time and may
spread through one or several communities.
 Pandemic: When an epidemic spreads
throughout the world. AIDS
3
Scope of the HIV/AIDS Pandemic
00002-E-4 – 1 December 2003
Adults and children estimated to be livingAdults and children estimated to be living
with HIV/AIDS as of end 2003with HIV/AIDS as of end 2003
Total: 34 – 46 million
Western Europe
520 000520 000 –– 680 000680 000
North Africa & Middle East
470 000470 000 –– 730 000730 000
Sub-Saharan Africa
25.025.0 –– 28.2 million28.2 million
Eastern Europe
& Central Asia
1.21.2 –– 1.8 million1.8 million
South
& South-East Asia
4.64.6 –– 8.2 million8.2 million
Australia
& New Zealand
12 00012 000 –– 18 00018 000
North America
790 000790 000 –– 1.2 million1.2 million
Caribbean
350 000350 000 –– 590 000590 000
Latin America
1.31.3 –– 1.9 million1.9 million
East Asia & Pacific
700 000700 000 –– 1.3 million1.3 million
4
Global HIV/AIDS in 2003
 40 million people are living with
HIV/AIDS.
 2.5 million are children under 15
years.
 14,000 new infections each day
5
Impact of Global HIV
Negative economic impact on countries
Overwhelmed healthcare systems
Decreasing life expectancy
Deteriorating child survival rates
Increasing numbers of orphans
6
HIV and AIDS
Human Immunodeficiency Virus
H = Human
I = Immunodeficiency
V = Virus
7
HIV
 Retrovirus, enveloped ssRNA, RT (RNA
dependent DNA polymerase).
 Lentiviruses (HIV1 and 2),
and Oncoviruses (HTLVI, HTLVII).
 Fastidius, requires intimate contact.
 Attacks CD4 + cells.
8
9
HIV life cycle
10
HIV and AIDS
Acquired ImmunoDeficiency Syndrome
A = not inherited
I = immune system
D =
deficiency – inability to protect against
illness
S =
syndrome, a group of symptoms or
illnesses that occur as a result of HIV
infection
11
HIV and AIDS
 When the immune system becomes
weakened by HIV, the illness
progresses to AIDS.
 Some blood tests, symptoms or
infections indicate progression of
HIV to AIDS.
12
HIV-1 and HIV-2
 HIV-1 and HIV-2
 Transmitted through the same routes
 Associated with similar opportunistic
infections
 HIV-1 is more common worldwide.
 HIV-2 is found primarily in West Africa,
Mozambique and Angola.
13
HIV-1 and HIV-2
Differences between HIV-1 and
HIV-2
 HIV-2 is less easily transmitted.
 HIV-2 develops more slowly.
 MTCT is relatively rare with HIV-2.
14
Variation in HIV-1
 Most error-prone reverse transcriptase.
 Variability of the gp 120 antigen.
 Failure of the immune system to control the
infection.
15
Natural History of HIV Infection
16
Natural History of HIV Infection
HIV can be transmitted during each stage
 Seroconversion
 Infection with HIV, antibodies develop
 Asymptomatic
 No signs of HIV, immune system controls
virus production
 Symptomatic
 Physical signs of HIV infection, some
immune suppression
 AIDS
 Opportunistic infections, end-stage disease
17
Natural History of HIV
Infection
 Severity of illness is
determined by amount
of virus in the body
(increasing viral load)
and the degree of
immune suppression
(decreasing CD4 count).
 Higher the viral load, the
sooner immune
suppression occurs.
18
Natural History of HIV Infection
Immune suppression
 HIV attacks white blood cells, called
CD4 cells, that protect body from
illness.
 Over time, the body’s ability to fight
common infections is lost.
 Opportunistic infections occur.
19
Natural History of HIV Infection
Direct infection of organ systems
Brain (HIV dementia)
Gut (wasting)
Heart (cardiomyopathy)
20
_______________Head_________________
_
Toxoplasmosis (Toxo)
Cryptococcal meningitis
_______________Eyes__________________
Cytomegalovirus (CMV)
___________Mouth and Throat__________
Candidiasis (Yeast)
________________Lungs_______________
_
Pneumocystis carinii pneumonia (PCP)
Tuberculosis (TB)
Histoplasmosis
_________________Gut_________________
Cytomegalovirus (CMV)
Cryptosporidiosis
Mycobacterium avium complex (MAC)
________________Skin_________________
Herpes simplex
Shingles
_______________Genitals______________
Genital herpes
Human papillomavirus (HPV)
Vaginal candidiasis (Yeast)
HIV-Related Opportunistic
Infections
21
Progression of HIV Infection
 HIGH viral load (number of copies of HIV in the
blood)
 LOW CD4 count (type of white blood cell)
 Increasing clinical symptoms (such as
opportunistic infections)
22
Natural History of HIV
Infection-Summary
 HIV multiplies inside the CD4 cells, destroying them.
 As CD4 cell count decreases and viral load increases, the
immune defences are weakened.
 People infected with HIV become vulnerable to opportunistic
infections.
 HIV is a chronic viral infection with no known cure.
 Without ARV treatment, HIV progresses to symptomatic
disease and AIDS.
23
Transmission of HIV
HIV is transmitted by
 Direct contact with infected blood
 Sexual contact: oral, anal or vaginal
 Direct contact with semen or vaginal and
cervical secretions
 Mothers infected with HIV to infants during
pregnancy, delivery and breastfeeding
24
 Coughing,
sneezing
 Insect bites
 Touching, hugging
 Water, food
 Kissing
 Public baths/pools
Transmission of HIV
HIV cannot be transmitted by:
 Toilets
 Handshakes
 Work or school contact
 Telephones
 Cups, glasses,
plates, or other utensils
25
Prevention of HIV Transmission
Public health strategies to prevent HIV transmission
 Screen all blood and blood products.
 Follow universal precautions.
 Educate in safer sex practises.
 Identify and treat STIs.
 Provide referral for treatment of drug
dependence.
 Apply the comprehensive PMTCT approach to
prevent perinatal transmission of HIV.
26
Antiretroviral Therapy
A. Nucleoside Reverse Transcriptase Inhibitors
1. Zidovudine (AZT, ZDV)
2. ddI (didanosine)
3. ddC (zalcitabine)
4. d4T (stavudine)
5. 3TC (lamivudine)
B. Non-nucleoside Reverse Transcriptase Inhibitors
1. Nevirapine
2. Delavirdine
C. Protease Inhibitors (PI's)
1. Indinavir (Crixivan)
2. Ritonavir (Norvir)
3. Nelfinavir mesylate (Viracept)
4. Saquinavir (Invirase)
27
References
 Introduction to Microbiology – A Case-
History Approach, by Ingraham and
Ingraham
 PMTCT Generic Training Package Module
1, from WHO website.
 http://aids.about.com/
28
Thank You

Contenu connexe

Tendances (20)

Human immunodeficiency virus(hiv)
Human immunodeficiency virus(hiv)Human immunodeficiency virus(hiv)
Human immunodeficiency virus(hiv)
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
HIV AIDS presentation
HIV AIDS presentationHIV AIDS presentation
HIV AIDS presentation
 
HIV and AIDS
HIV and AIDSHIV and AIDS
HIV and AIDS
 
Hiv infection !!
Hiv infection !!Hiv infection !!
Hiv infection !!
 
HIV-AIDS
HIV-AIDSHIV-AIDS
HIV-AIDS
 
HIV
HIVHIV
HIV
 
Aids ppt
Aids pptAids ppt
Aids ppt
 
Human immunodeficiency virus (hiv) and aids
Human immunodeficiency virus (hiv) and aidsHuman immunodeficiency virus (hiv) and aids
Human immunodeficiency virus (hiv) and aids
 
Aids
AidsAids
Aids
 
Aids Powerpoint
Aids PowerpointAids Powerpoint
Aids Powerpoint
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
HIV-AIDS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPORE KASHMIR
HIV-AIDS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPORE KASHMIRHIV-AIDS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPORE KASHMIR
HIV-AIDS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPORE KASHMIR
 
HIV
HIVHIV
HIV
 
Hiv infection and aids
Hiv infection and aidsHiv infection and aids
Hiv infection and aids
 
HIV
HIVHIV
HIV
 
HIV and AIDS
HIV and AIDSHIV and AIDS
HIV and AIDS
 
HIV
HIVHIV
HIV
 
HIV AND AIDS
HIV AND AIDSHIV AND AIDS
HIV AND AIDS
 
History of HIV/AIDS
History of HIV/AIDSHistory of HIV/AIDS
History of HIV/AIDS
 

En vedette (20)

Power point hiv aids
Power point hiv aidsPower point hiv aids
Power point hiv aids
 
Penyuluhan HIV/AIDS
Penyuluhan HIV/AIDSPenyuluhan HIV/AIDS
Penyuluhan HIV/AIDS
 
Penyuluhan HIV/AIDS
Penyuluhan HIV/AIDSPenyuluhan HIV/AIDS
Penyuluhan HIV/AIDS
 
HIV infection (AIDS)
HIV infection (AIDS)HIV infection (AIDS)
HIV infection (AIDS)
 
Chancroid
ChancroidChancroid
Chancroid
 
Hiv aids smu
Hiv aids smuHiv aids smu
Hiv aids smu
 
Secondary Immunodeficiency
Secondary ImmunodeficiencySecondary Immunodeficiency
Secondary Immunodeficiency
 
Projeto AIDS - João Victor
Projeto AIDS - João VictorProjeto AIDS - João Victor
Projeto AIDS - João Victor
 
Aids.2
Aids.2Aids.2
Aids.2
 
Aids[1]
Aids[1]Aids[1]
Aids[1]
 
LABORATORY DIAGNOSIS OF HIV - AIDS
LABORATORY DIAGNOSIS OF HIV - AIDSLABORATORY DIAGNOSIS OF HIV - AIDS
LABORATORY DIAGNOSIS OF HIV - AIDS
 
Laboratory diagnosis of HIV infection.
Laboratory diagnosis of HIV infection.Laboratory diagnosis of HIV infection.
Laboratory diagnosis of HIV infection.
 
AIDS/HIV Testing Methodology (www.ubio.in)
AIDS/HIV Testing Methodology (www.ubio.in)AIDS/HIV Testing Methodology (www.ubio.in)
AIDS/HIV Testing Methodology (www.ubio.in)
 
Malayalam powerpoint
Malayalam powerpointMalayalam powerpoint
Malayalam powerpoint
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
Power point
Power pointPower point
Power point
 
Comprehensive Presentation on HIV/AIDS
Comprehensive Presentation on HIV/AIDSComprehensive Presentation on HIV/AIDS
Comprehensive Presentation on HIV/AIDS
 
Aids – A Secondary Immunodeficiency Disorder
Aids – A Secondary Immunodeficiency DisorderAids – A Secondary Immunodeficiency Disorder
Aids – A Secondary Immunodeficiency Disorder
 
Addison’s Disease
Addison’s DiseaseAddison’s Disease
Addison’s Disease
 
Addison's Disease powerpoint
Addison's Disease powerpointAddison's Disease powerpoint
Addison's Disease powerpoint
 

Similaire à Everything You Need to Know About HIV/AIDS

hivfinal-180417201129.pdf
hivfinal-180417201129.pdfhivfinal-180417201129.pdf
hivfinal-180417201129.pdfMargamKamdak
 
hiv final management -180417201129.pdf
hiv final  management  -180417201129.pdfhiv final  management  -180417201129.pdf
hiv final management -180417201129.pdfdeborayilma
 
hiv / aids final managment -180417201129.pdf
hiv / aids final managment -180417201129.pdfhiv / aids final managment -180417201129.pdf
hiv / aids final managment -180417201129.pdfdeborayilma
 
Presentation on HIV-AIDS - Copy.pptx
Presentation on HIV-AIDS - Copy.pptxPresentation on HIV-AIDS - Copy.pptx
Presentation on HIV-AIDS - Copy.pptxRebecca56466
 
Hivaids sachin bhatt
Hivaids sachin bhattHivaids sachin bhatt
Hivaids sachin bhattSachin Bhatt
 
Human immune deficiency syndrome
Human immune deficiency syndromeHuman immune deficiency syndrome
Human immune deficiency syndromeZain Khadim
 
HIV AIDS skin manifestations n management .pptx
HIV AIDS skin manifestations n management .pptxHIV AIDS skin manifestations n management .pptx
HIV AIDS skin manifestations n management .pptxAbhishekGupta920331
 
Prevention Of HIV/AIDS
Prevention Of HIV/AIDSPrevention Of HIV/AIDS
Prevention Of HIV/AIDSSoumar Dutta
 
Lecture 5-human immunodeficiency
Lecture 5-human immunodeficiencyLecture 5-human immunodeficiency
Lecture 5-human immunodeficiencysaid warsame
 
HIV By Dr CB Narayan
HIV By Dr CB NarayanHIV By Dr CB Narayan
HIV By Dr CB NarayanDr CB Narayan
 
the aids epidemic in africa
the aids epidemic in africathe aids epidemic in africa
the aids epidemic in africaweepingmarylou
 

Similaire à Everything You Need to Know About HIV/AIDS (20)

Final pptct mod 1
Final pptct mod 1Final pptct mod 1
Final pptct mod 1
 
Marina arutinovi 2
Marina arutinovi 2Marina arutinovi 2
Marina arutinovi 2
 
HIV/AIDS
HIV/AIDS HIV/AIDS
HIV/AIDS
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
HIV AIDS intoduction
HIV AIDS intoductionHIV AIDS intoduction
HIV AIDS intoduction
 
32331.ppt
32331.ppt32331.ppt
32331.ppt
 
hivfinal-180417201129.pdf
hivfinal-180417201129.pdfhivfinal-180417201129.pdf
hivfinal-180417201129.pdf
 
hiv final management -180417201129.pdf
hiv final  management  -180417201129.pdfhiv final  management  -180417201129.pdf
hiv final management -180417201129.pdf
 
hiv / aids final managment -180417201129.pdf
hiv / aids final managment -180417201129.pdfhiv / aids final managment -180417201129.pdf
hiv / aids final managment -180417201129.pdf
 
HIV/AIDS Management
HIV/AIDS ManagementHIV/AIDS Management
HIV/AIDS Management
 
HIV AND PERIODONTAL DISEASE
HIV AND PERIODONTAL DISEASEHIV AND PERIODONTAL DISEASE
HIV AND PERIODONTAL DISEASE
 
AIDS/HIV/drugs
AIDS/HIV/drugs AIDS/HIV/drugs
AIDS/HIV/drugs
 
Presentation on HIV-AIDS - Copy.pptx
Presentation on HIV-AIDS - Copy.pptxPresentation on HIV-AIDS - Copy.pptx
Presentation on HIV-AIDS - Copy.pptx
 
Hivaids sachin bhatt
Hivaids sachin bhattHivaids sachin bhatt
Hivaids sachin bhatt
 
Human immune deficiency syndrome
Human immune deficiency syndromeHuman immune deficiency syndrome
Human immune deficiency syndrome
 
HIV AIDS skin manifestations n management .pptx
HIV AIDS skin manifestations n management .pptxHIV AIDS skin manifestations n management .pptx
HIV AIDS skin manifestations n management .pptx
 
Prevention Of HIV/AIDS
Prevention Of HIV/AIDSPrevention Of HIV/AIDS
Prevention Of HIV/AIDS
 
Lecture 5-human immunodeficiency
Lecture 5-human immunodeficiencyLecture 5-human immunodeficiency
Lecture 5-human immunodeficiency
 
HIV By Dr CB Narayan
HIV By Dr CB NarayanHIV By Dr CB Narayan
HIV By Dr CB Narayan
 
the aids epidemic in africa
the aids epidemic in africathe aids epidemic in africa
the aids epidemic in africa
 

Dernier

The byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxThe byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxShobhayan Kirtania
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...anjaliyadav012327
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...Pooja Nehwal
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 

Dernier (20)

The byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxThe byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 

Everything You Need to Know About HIV/AIDS

  • 1. HIV / AIDS -Malini Sundar Rajan 7th semester BE Biotechnology PESIT
  • 2. 2 Endemic, Epidemic and Pandemic – The Difference  Endemic: a disease that exists permanently in a particular region or population. Malaria is a constant worry in parts of Africa.  Epidemic: An outbreak of disease that attacks many peoples at about the same time and may spread through one or several communities.  Pandemic: When an epidemic spreads throughout the world. AIDS
  • 3. 3 Scope of the HIV/AIDS Pandemic 00002-E-4 – 1 December 2003 Adults and children estimated to be livingAdults and children estimated to be living with HIV/AIDS as of end 2003with HIV/AIDS as of end 2003 Total: 34 – 46 million Western Europe 520 000520 000 –– 680 000680 000 North Africa & Middle East 470 000470 000 –– 730 000730 000 Sub-Saharan Africa 25.025.0 –– 28.2 million28.2 million Eastern Europe & Central Asia 1.21.2 –– 1.8 million1.8 million South & South-East Asia 4.64.6 –– 8.2 million8.2 million Australia & New Zealand 12 00012 000 –– 18 00018 000 North America 790 000790 000 –– 1.2 million1.2 million Caribbean 350 000350 000 –– 590 000590 000 Latin America 1.31.3 –– 1.9 million1.9 million East Asia & Pacific 700 000700 000 –– 1.3 million1.3 million
  • 4. 4 Global HIV/AIDS in 2003  40 million people are living with HIV/AIDS.  2.5 million are children under 15 years.  14,000 new infections each day
  • 5. 5 Impact of Global HIV Negative economic impact on countries Overwhelmed healthcare systems Decreasing life expectancy Deteriorating child survival rates Increasing numbers of orphans
  • 6. 6 HIV and AIDS Human Immunodeficiency Virus H = Human I = Immunodeficiency V = Virus
  • 7. 7 HIV  Retrovirus, enveloped ssRNA, RT (RNA dependent DNA polymerase).  Lentiviruses (HIV1 and 2), and Oncoviruses (HTLVI, HTLVII).  Fastidius, requires intimate contact.  Attacks CD4 + cells.
  • 8. 8
  • 10. 10 HIV and AIDS Acquired ImmunoDeficiency Syndrome A = not inherited I = immune system D = deficiency – inability to protect against illness S = syndrome, a group of symptoms or illnesses that occur as a result of HIV infection
  • 11. 11 HIV and AIDS  When the immune system becomes weakened by HIV, the illness progresses to AIDS.  Some blood tests, symptoms or infections indicate progression of HIV to AIDS.
  • 12. 12 HIV-1 and HIV-2  HIV-1 and HIV-2  Transmitted through the same routes  Associated with similar opportunistic infections  HIV-1 is more common worldwide.  HIV-2 is found primarily in West Africa, Mozambique and Angola.
  • 13. 13 HIV-1 and HIV-2 Differences between HIV-1 and HIV-2  HIV-2 is less easily transmitted.  HIV-2 develops more slowly.  MTCT is relatively rare with HIV-2.
  • 14. 14 Variation in HIV-1  Most error-prone reverse transcriptase.  Variability of the gp 120 antigen.  Failure of the immune system to control the infection.
  • 15. 15 Natural History of HIV Infection
  • 16. 16 Natural History of HIV Infection HIV can be transmitted during each stage  Seroconversion  Infection with HIV, antibodies develop  Asymptomatic  No signs of HIV, immune system controls virus production  Symptomatic  Physical signs of HIV infection, some immune suppression  AIDS  Opportunistic infections, end-stage disease
  • 17. 17 Natural History of HIV Infection  Severity of illness is determined by amount of virus in the body (increasing viral load) and the degree of immune suppression (decreasing CD4 count).  Higher the viral load, the sooner immune suppression occurs.
  • 18. 18 Natural History of HIV Infection Immune suppression  HIV attacks white blood cells, called CD4 cells, that protect body from illness.  Over time, the body’s ability to fight common infections is lost.  Opportunistic infections occur.
  • 19. 19 Natural History of HIV Infection Direct infection of organ systems Brain (HIV dementia) Gut (wasting) Heart (cardiomyopathy)
  • 20. 20 _______________Head_________________ _ Toxoplasmosis (Toxo) Cryptococcal meningitis _______________Eyes__________________ Cytomegalovirus (CMV) ___________Mouth and Throat__________ Candidiasis (Yeast) ________________Lungs_______________ _ Pneumocystis carinii pneumonia (PCP) Tuberculosis (TB) Histoplasmosis _________________Gut_________________ Cytomegalovirus (CMV) Cryptosporidiosis Mycobacterium avium complex (MAC) ________________Skin_________________ Herpes simplex Shingles _______________Genitals______________ Genital herpes Human papillomavirus (HPV) Vaginal candidiasis (Yeast) HIV-Related Opportunistic Infections
  • 21. 21 Progression of HIV Infection  HIGH viral load (number of copies of HIV in the blood)  LOW CD4 count (type of white blood cell)  Increasing clinical symptoms (such as opportunistic infections)
  • 22. 22 Natural History of HIV Infection-Summary  HIV multiplies inside the CD4 cells, destroying them.  As CD4 cell count decreases and viral load increases, the immune defences are weakened.  People infected with HIV become vulnerable to opportunistic infections.  HIV is a chronic viral infection with no known cure.  Without ARV treatment, HIV progresses to symptomatic disease and AIDS.
  • 23. 23 Transmission of HIV HIV is transmitted by  Direct contact with infected blood  Sexual contact: oral, anal or vaginal  Direct contact with semen or vaginal and cervical secretions  Mothers infected with HIV to infants during pregnancy, delivery and breastfeeding
  • 24. 24  Coughing, sneezing  Insect bites  Touching, hugging  Water, food  Kissing  Public baths/pools Transmission of HIV HIV cannot be transmitted by:  Toilets  Handshakes  Work or school contact  Telephones  Cups, glasses, plates, or other utensils
  • 25. 25 Prevention of HIV Transmission Public health strategies to prevent HIV transmission  Screen all blood and blood products.  Follow universal precautions.  Educate in safer sex practises.  Identify and treat STIs.  Provide referral for treatment of drug dependence.  Apply the comprehensive PMTCT approach to prevent perinatal transmission of HIV.
  • 26. 26 Antiretroviral Therapy A. Nucleoside Reverse Transcriptase Inhibitors 1. Zidovudine (AZT, ZDV) 2. ddI (didanosine) 3. ddC (zalcitabine) 4. d4T (stavudine) 5. 3TC (lamivudine) B. Non-nucleoside Reverse Transcriptase Inhibitors 1. Nevirapine 2. Delavirdine C. Protease Inhibitors (PI's) 1. Indinavir (Crixivan) 2. Ritonavir (Norvir) 3. Nelfinavir mesylate (Viracept) 4. Saquinavir (Invirase)
  • 27. 27 References  Introduction to Microbiology – A Case- History Approach, by Ingraham and Ingraham  PMTCT Generic Training Package Module 1, from WHO website.  http://aids.about.com/

Notes de l'éditeur

  1. <number>
  2. <number>
  3. <number>
  4. <number>
  5. <number>
  6. <number>
  7. <number>
  8. <number>
  9. <number>
  10. <number>
  11. <number>
  12. <number>
  13. <number>
  14. <number>
  15. <number>
  16. <number>
  17. <number>